Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AXL-IN-14 is a potent, orally active inhibitor of AXL with an IC50 of 0.8 nM that effectively suppresses Gas6/AXL-mediated cell migration and invasion, reduces the expression of p-AXL and p-AKT proteins, and demonstrates anti-tumor activity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | AXL-IN-14 is a potent, orally active inhibitor of AXL with an IC50 of 0.8 nM that effectively suppresses Gas6/AXL-mediated cell migration and invasion, reduces the expression of p-AXL and p-AKT proteins, and demonstrates anti-tumor activity [1]. |
In vitro | AXL-IN-14, at concentrations of 0.2, 1, and 5 nM for 1 hour, demonstrated a dose-dependent decrease in the expression levels of p-AXL and p-AKT proteins [1]. With a 72-hour exposure, AXL-IN-14 exhibited antiproliferative activity, achieving an IC50 value of 21.8 nM in EBC-1 cells [1]. Additionally, AXL-IN-14, at 20 and 100 nM for 24 hours, inhibited Gas6/AXL-mediated cell migration and invasion in H1299 and SNU449 cells [1]. |
In vivo | AXL-IN-14 (1, 10 mg/kg; p.o.; once daily for 11 days) demonstrated antitumor activity in nude mice [1]. |
Molecular Weight | 566.55 |
Formula | C32H24F2N4O4 |
CAS No. | 2947506-65-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AXL-IN-14 2947506-65-0 Tyrosine Kinase/Adaptors TAM Receptor inhibitor inhibit